NASDAQ
Abbott Laboratories (ABT) reported revenue of $44.33B and net income of $6.52B for FY 2025. The gross profit margin is 55.5% with a net profit margin of 14.7%.
Financial data for ABT
5.67% YoY
51.32% YoY
51.24% YoY
Annual Income Statement for ABT
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $44B | $42B | $40B | $44B | $43B |
| Cost of Revenue | $20B | $21B | $20B | $21B | $20B |
| Gross Profit | $25B | $21B | $20B | $22B | $23B |
| Operating Expenses | $17B | $14B | $14B | $14B | $14B |
| Operating Income | $8B | $7B | $6B | $8B | $9B |
| Net Income | $7B | $13B | $6B | $7B | $7B |
| EPS | $3.74 | $7.67 | $3.30 | $3.94 | $3.97 |
| EBITDA | $12B | $11B | $11B | $12B | $12B |
No price data available for this timeframe.